Tacrolimus Co-administration Suppresses Anti-donor Immune Response to Allogeneic Mesenchymal Stem Cells but does not Influence Disease Severity in a Mouse Model of Hind Limb Ischemia

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputAbstract
Volume21
Publication statusPublished - 1 Sep 2015

Cite this